PL3890828T3 - Związki heteroaromatyczne jako inhibitory wanin - Google Patents
Związki heteroaromatyczne jako inhibitory waninInfo
- Publication number
- PL3890828T3 PL3890828T3 PL19813499.1T PL19813499T PL3890828T3 PL 3890828 T3 PL3890828 T3 PL 3890828T3 PL 19813499 T PL19813499 T PL 19813499T PL 3890828 T3 PL3890828 T3 PL 3890828T3
- Authority
- PL
- Poland
- Prior art keywords
- heteroaromatic compounds
- vanin
- inhibitors
- vanin inhibitors
- heteroaromatic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862774412P | 2018-12-03 | 2018-12-03 | |
| PCT/EP2019/083259 WO2020114947A1 (en) | 2018-12-03 | 2019-12-02 | Heteroaromatic compounds as vanin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3890828T3 true PL3890828T3 (pl) | 2025-06-16 |
Family
ID=68766765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19813499.1T PL3890828T3 (pl) | 2018-12-03 | 2019-12-02 | Związki heteroaromatyczne jako inhibitory wanin |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12240828B2 (pl) |
| EP (1) | EP3890828B1 (pl) |
| JP (1) | JP7195436B2 (pl) |
| KR (1) | KR20210099093A (pl) |
| CN (1) | CN113226462B (pl) |
| AU (1) | AU2019392524B2 (pl) |
| BR (1) | BR112021010823A2 (pl) |
| CA (1) | CA3120037A1 (pl) |
| DK (1) | DK3890828T3 (pl) |
| EA (1) | EA202191478A1 (pl) |
| ES (1) | ES3026660T3 (pl) |
| HU (1) | HUE070992T2 (pl) |
| MX (1) | MX2021006489A (pl) |
| PL (1) | PL3890828T3 (pl) |
| WO (1) | WO2020114947A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL283397B2 (en) * | 2018-12-03 | 2025-03-01 | Boehringer Ingelheim Int | Heteroaromatic compounds as vanin inhibitors |
| WO2020123426A1 (en) * | 2018-12-11 | 2020-06-18 | F. Hoffmann-La Roche Ag | Aminoazine amides |
| IL301556A (en) * | 2020-09-25 | 2023-05-01 | Shanghai Meiyue Biotech Dev Co Ltd | Pyrimidine carboxamide compound and its use |
| TWI811901B (zh) * | 2020-12-17 | 2023-08-11 | 大陸商上海美悅生物科技發展有限公司 | 一種嘧啶甲醯胺類化合物及其應用 |
| US20250197414A1 (en) * | 2022-03-18 | 2025-06-19 | Shanghai Meiyue Biotech Development Co., Ltd. | Salt form and crystal form of vanin enzyme inhibitor, method for preparing same, and use thereof |
| CN116903592B (zh) * | 2023-07-13 | 2025-08-01 | 特科罗生物科技(成都)有限公司 | 一种嘧啶胺类nuak抑制剂及其制备方法和用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030195192A1 (en) | 2002-04-05 | 2003-10-16 | Fortuna Haviv | Nicotinamides having antiangiogenic activity |
| DE602004018811D1 (de) | 2003-10-09 | 2009-02-12 | Abbott Lab | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |
| CN103087050A (zh) * | 2011-10-28 | 2013-05-08 | 山东轩竹医药科技有限公司 | 芳基激酶抑制剂 |
| US9585891B2 (en) | 2012-09-25 | 2017-03-07 | Merck Patent Gmbh | Alpha hydroxy amides |
| US9221807B2 (en) * | 2014-02-21 | 2015-12-29 | Boehringer Ingelheim International Gmbh | Substituted pyridones and pyrazinones and their use as inhibitors of neutrophil elastase activity |
| JP2018516254A (ja) * | 2015-05-29 | 2018-06-21 | ファイザー・インク | バニン1酵素の阻害薬としての新規なヘテロ環化合物 |
| JP6976947B2 (ja) * | 2015-12-16 | 2021-12-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 自己免疫疾患の処置に有用なビピラゾリル誘導体 |
| EP3484876A1 (en) * | 2016-07-14 | 2019-05-22 | Pfizer Inc | Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme |
| AU2018285131B2 (en) | 2017-06-12 | 2021-11-11 | Boehringer Ingelheim International Gmbh | Heteroaromatic compounds as Vanin inhibitors |
| AU2019326933B2 (en) | 2018-08-28 | 2024-12-05 | Boehringer Ingelheim International Gmbh | Heteroaromatic compounds as Vanin inhibitors |
| IL283397B2 (en) * | 2018-12-03 | 2025-03-01 | Boehringer Ingelheim Int | Heteroaromatic compounds as vanin inhibitors |
-
2019
- 2019-12-02 MX MX2021006489A patent/MX2021006489A/es unknown
- 2019-12-02 CA CA3120037A patent/CA3120037A1/en active Pending
- 2019-12-02 EA EA202191478A patent/EA202191478A1/ru unknown
- 2019-12-02 US US17/299,148 patent/US12240828B2/en active Active
- 2019-12-02 CN CN201980079064.6A patent/CN113226462B/zh active Active
- 2019-12-02 EP EP19813499.1A patent/EP3890828B1/en active Active
- 2019-12-02 KR KR1020217020909A patent/KR20210099093A/ko active Pending
- 2019-12-02 WO PCT/EP2019/083259 patent/WO2020114947A1/en not_active Ceased
- 2019-12-02 JP JP2021531394A patent/JP7195436B2/ja active Active
- 2019-12-02 PL PL19813499.1T patent/PL3890828T3/pl unknown
- 2019-12-02 DK DK19813499.1T patent/DK3890828T3/da active
- 2019-12-02 ES ES19813499T patent/ES3026660T3/es active Active
- 2019-12-02 BR BR112021010823-8A patent/BR112021010823A2/pt unknown
- 2019-12-02 HU HUE19813499A patent/HUE070992T2/hu unknown
- 2019-12-02 AU AU2019392524A patent/AU2019392524B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210099093A (ko) | 2021-08-11 |
| JP2022510351A (ja) | 2022-01-26 |
| HUE070992T2 (hu) | 2025-07-28 |
| BR112021010823A2 (pt) | 2021-08-24 |
| CA3120037A1 (en) | 2020-06-11 |
| CN113226462A (zh) | 2021-08-06 |
| AU2019392524B2 (en) | 2025-05-08 |
| ES3026660T3 (en) | 2025-06-11 |
| US20220048889A1 (en) | 2022-02-17 |
| EP3890828B1 (en) | 2025-02-19 |
| JP7195436B2 (ja) | 2022-12-23 |
| MX2021006489A (es) | 2021-07-06 |
| EP3890828A1 (en) | 2021-10-13 |
| US12240828B2 (en) | 2025-03-04 |
| AU2019392524A1 (en) | 2021-07-15 |
| EA202191478A1 (ru) | 2021-10-26 |
| DK3890828T3 (da) | 2025-05-05 |
| CN113226462B (zh) | 2025-02-11 |
| WO2020114947A1 (en) | 2020-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2400003I1 (hu) | Kináz inhibitorként alkalmas vegyületek | |
| IL289474A (en) | Substituted thiazolo-pyridine compounds as malt1 inhibitors | |
| ZA202002770B (en) | Imidazo-pyridine compounds as pad inhibitors | |
| IL271104B (en) | Heteroaromatic compounds as vanin inhibitors | |
| IL283397A (en) | Heteroaromatic compounds as vanin inhibitors | |
| IL280898A (en) | Heteroaromatic compounds as vanin inhibitors | |
| PL3371190T3 (pl) | Związki heterocykliczne jako inhibitory pi3k-gamma | |
| HUE070992T2 (hu) | Heteroaromás vegyületek mint vanin gátlók | |
| IL255750A (en) | Heterocyclic compounds as kinase inhibitors | |
| IL282659A (en) | Heterocyclic compounds as bet inhibitors | |
| IL271808A (en) | Novel mutated azaindoline derivatives as NIK inhibitors | |
| PL3891142T3 (pl) | Związki heteroaromatyczne jako inhibitory waniny | |
| LT3589637T (lt) | Junginiai, naudotini ror-gama-t slopinimui | |
| HK40055124A (en) | Heteroaromatic compounds as vanin inhibitors | |
| HK40057193A (en) | Heteroaromatic compounds as vanin inhibitors | |
| HK40019019A (en) | Heteroaromatic compounds as vanin inhibitors | |
| IL264465B (en) | Substituted thiazolo-pyridine compounds as malt1 inhibitors | |
| GB201613945D0 (en) | Compounds useful as kinase inhibitors | |
| GB201522245D0 (en) | Compounds useful as kinase inhibitors |